SVU On Demand Webinar 111924: The Dialysis Patient: Hemodialysis Imaging from Preoperative Assessment to Post-operative Imaging
The Dialysis Patient: Hemodialysis Imaging from Preoperative Assessment to Post-operative Imaging
J7053A-24-T
LEARNING OBJECTIVES
- Discuss Capabilities, Limitations and Imaging Techniques
- Define the Preoperative Evaluation Process
- Define Imaging Protocol
- Define Duplex Criteria
- Define Arteriovenous Fistulas (AVF’s) vs. Arteriovenous Grafts (AVG’s)
- Explain Staged Procedures
- Define Post Operative Complications
TARGET AUDIENCE
Physician, Nurses, Vascular Technologist and Sonographer members of SVU should find participating in this educational activity valuable.
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and the Society for Vascular Ultrasound. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Penn State College of Medicine designates this Enduring Material activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.
CREDIT AVAILABILITY
Activity release date: November 30, 2024
Expiration date: October 31, 2027
METHOD OF PARTICIPATION
This Enduring Material activity is available online at www.svu.org. To receive credit, participants must view the on-demand video, including the learning objectives and disclosure statements, as well as the full content, and then complete the post test and evaluation form. Upon successful completion of the post-test (80% correct) and evaluation form, a CME certificate of participation will be awarded automatically. The certificate may be printed directly from the website.
DISCLOSURE
Penn State College of Medicine is committed to offering CME activities that promote improvements or quality in health care and are developed free of the control of ineligible companies (formerly known as a commercial interests). Reasonable efforts have been taken to ensure that our activities are balanced, independent, objective, scientific, and in compliance with regulatory requirements. All authors have disclosed all relevant financial relationships with ineligible companies, and Penn State has a process in place to mitigate any conflict of interest. Disclosure of a relationship is not intended to suggest or condone bias in an article but is made to provide participants with information that might be of potential importance to their evaluation of an article.
Devices or drugs that are still undergoing clinical trials should not be portrayed as standard, accepted therapy. Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing physician to monitor the medical literature to determine recommended dosages and uses of the drugs.
The information presented at this CME activity represents the views and opinions of the individual authors, and does not constitute the opinion or endorsement of, or promotion by, Penn State College of Medicine. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Laurie Lozanski BS RVS RVT– Nothing to disclose
Matthew Allen, MHA, RPhS, RVS, RVT– Nothing to disclose
Penn State Continuing Education staff involved in the planning of this activity have no financial relationships with any ineligible companies relevant to this activity.
Speakers/Authors are required to inform the activity audience when they are discussing/describing off-label or investigational uses of devices or drugs.